Statements (97)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquisition |
gptkb:Ablynx
|
| gptkbp:clinical_trial |
multiple drug candidates
Phase 3 trials |
| gptkbp:collaboration |
academic institutions
|
| gptkbp:employees |
over 600
|
| gptkbp:focus |
drug discovery
|
| gptkbp:founded |
gptkb:1999
|
| gptkbp:founder |
Onno van de Stolpe
|
| gptkbp:headquarters |
gptkb:Mechelen,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
Galapagos NV
|
| gptkbp:instruction_set |
various therapeutic areas
|
| gptkbp:partnership |
gptkb:Gilead_Sciences
|
| gptkbp:product |
gptkb:Filgotinib
GLPG-1205 GLPG-1690 GLPG-1972 GLPG-2737 GLPG-3667 GLPG-3970 GLPG-5111 GLPG-5251 GLPG-5419 GLPG-5866 GLPG-6321 GLPG-6396 GLPG-6864 GLPG-6931 GLPG-7301 GLPG-7334 GLPG-7356 GLPG-7374 GLPG-7401 GLPG-7418 GLPG-7430 GLPG-7461 GLPG-7480 GLPG-7490 GLPG-7500 GLPG-7510 GLPG-7520 GLPG-7530 GLPG-7540 GLPG-7550 GLPG-7560 GLPG-7570 GLPG-7580 GLPG-7590 GLPG-7600 GLPG-7610 GLPG-7620 GLPG-7630 GLPG-7640 GLPG-7650 GLPG-7660 GLPG-7670 GLPG-7680 GLPG-7690 GLPG-7700 GLPG-7710 GLPG-7720 GLPG-7730 GLPG-7740 GLPG-7750 GLPG-7760 GLPG-7770 GLPG-7780 GLPG-7790 GLPG-7800 GLPG-7810 GLPG-7820 GLPG-7830 GLPG-7840 GLPG-7850 GLPG-7860 GLPG-7870 GLPG-7880 GLPG-7890 GLPG-7900 GLPG-7910 GLPG-7920 GLPG-7930 GLPG-7940 GLPG-7950 GLPG-7960 GLPG-7970 GLPG-7980 GLPG-7990 GLPG-8000 |
| gptkbp:research_areas |
oncology
inflammation fibrosis neurodegeneration |
| gptkbp:revenue |
€ 200 million (2020)
|
| gptkbp:traded_on |
gptkb:Euronext_Amsterdam
|
| gptkbp:bfsParent |
gptkb:Gilead_Sciences
|
| gptkbp:bfsLayer |
4
|